Biochemical and biological characteristics of cross-reacting material 197 (CRM197), a non-toxic mutant of diphtheria toxin: use as a conjugation protein in vaccines …

M Bröker, P Costantino, L DeTora, ED McIntosh… - Biologicals, 2011 - Elsevier
The biochemical and biological characteristics of CRM 197 are reviewed. Polysaccharide
protein conjugate vaccines represent an important technological advancement that allowed for …

Chemistry of a new investigational quadrivalent meningococcal conjugate vaccine that is immunogenic at all ages

M Bröker, PM Dull, R Rappuoli, P Costantino - Vaccine, 2009 - Elsevier
Meningococcal disease is a serious medical condition that can prove fatal within hours in
otherwise healthy individuals. Disease incidence is highest in infants, yet there is no broadly …

Tick-borne encephalitis in mainland China

Z Lu, M Bröker, G Liang - Vector-borne and zoonotic diseases, 2008 - liebertpub.com
Tick-borne encephalitis (TBE) virus is one of the most important flavivirus infections of the
central nervous system in Europe and Russia, with 12,000 estimated human cases per year. At …

[HTML][HTML] Polysaccharide conjugate vaccine protein carriers as a “neglected valency”–Potential and limitations

M Bröker, F Berti, J Schneider, I Vojtek - Vaccine, 2017 - Elsevier
The development of vaccines against polysaccharide-encapsulated pathogens (eg
Haemophilus influenzae type b, pneumococci, meningococci) is challenging because …

[HTML][HTML] The Spatial Distribution of Dermacentor Ticks (Ixodidae) in Germany—Evidence of a Continuing Spread of Dermacentor reticulatus

…, CR Schneider, L Chitimia-Dobler, M Bröker… - Frontiers in veterinary …, 2020 - frontiersin.org
In Europe, two tick species of the genus Dermacentor occur, Dermacentor marginatus and
Dermacentor reticulatus. When the spatial distribution of both species in Germany was …

Safety of MDCK cell culture-based influenza vaccines

…, HJ Schmitt, H Trusheim, M Bröker - Future …, 2011 - Future Medicine
After more than 60 years, the conventional production of influenza vaccines employing
fertilized chicken eggs has reached its limits – both in terms of temporal flexibility and vaccine …

[BOOK][B] The TBE book

G Dobler, W Erber, M Bröker, HJ Schmitt - 2020 - books.google.com
While the number of vector-borne diseases and their incidence in Europe is much less than
in tropical and/or developing countries, there are nevertheless a substantial number of such …

Meningococcal serogroup Y disease in Europe: continuation of high importance in some European regions in 2013

M Bröker, S Emonet, C Fazio, S Jacobsson… - Human vaccines & …, 2015 - Taylor & Francis
Neisseria meningitidis or meningococcus is divided into 12 distinct serogroups of which A, B,
C, W, X, and Y are medically most important and cause health problems in different parts of …

[HTML][HTML] Invasive meningococcal disease and travel

ZA Memish, A Goubeaud, M Bröker, C Malerczyk… - Journal of Infection and …, 2010 - Elsevier
The epidemiology of invasive meningococcal disease varies geographically and in time
and the risk of acquiring the disease varies regionally, as well as with living conditions and …

Factors contributing to the immunogenicity of meningococcal conjugate vaccines

M Bröker, F Berti, P Costantino - Human Vaccines & …, 2016 - Taylor & Francis
Various glycoprotein conjugate vaccines have been developed for the prevention of invasive
meningococcal disease, having significant advantages over pure polysaccharide vaccines. …